| |
|
|
Korea United Pharm. Inc. (033270) |
|
|
STOCK |
|
|
| Address |
404-10,NOJANG-RI, JEONDONG-MYEON, YEONGI-GUN, CHUNGNAM |
| Home Page |
www.kup.co.kr
|
| Established |
1987.12. 3 |
Tel |
041-862-5030 |
| Listed |
2007.10.23 |
IR |
02-516-3041 |
| Common shares O/S |
15,025,924 |
President |
Kang,Duk Young |
| Preferred shares O/S |
|
No.of Employees |
244(2007.12) |
| Sales increased on strong sales networks and its technological competitiveness. Its profitability remained sound on increased sales of high-value drugs. Sales are expected to increase on rising demand for 19 new drugs such as anticancer drugs and diabetes drugs. |
| Its overseas affiliates posted a good performance, and the company is seeking to further raise its presence in oversea markets. Its profitability is expected to improve on decreased costs and steady sales of its main products. Its business performance is forecast to improve on its continued research and development. |
|
  |
(date: 2007.12, unit : %) |
| Name |
Kang Deogyeong |
|
|
| Portion |
45.3 |
|
|
|
 |
(unit : %) |
| Sales |
Antibiotics |
35.3 |
Cost |
Raw Materials |
|
| Gastrointestinal System Drugs |
15.3 |
Labors |
|
| Cycling Machine |
13.5 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
07.10 |
- |
- |
- |
- |
| Type |
LI |
- |
- |
- |
- |
| Amount |
75.13 |
- |
- |
- |
- |
|
|
|
|
